Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

Front Cover
Kenneth C. Shadlen, S. Guennif
Edward Elgar Publishing, Jan 1, 2011 - Medical - 352 pages
0 Reviews
'This impressive collection offers fascinating new perspectives on the impact of pharmaceutical patents on access to medicines in developing countries. The volume's editors have put together an important book that sets out clearly the challenges t
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

meeting the challenges to addressing health gaps in the new international environment
1
2 Pharmaceutical production and access to essential medicines in South Africa
29
paradoxes in Moroccan policy
56
trade intellectual property and pharmaceutical regulations in Colombia
77
5 The challenges of constructing pharmaceutical capabilities and promoting access to medicines in Mexico under TRIPS
110
Brazils use of TRIPS flexibilities for its National AIDS Program
149
the industrial bases of health policies
178
learning from the Canadian experience
202
emerging issues
225
a doubletrack system that facilitated supply capability in China
253
intellectual property rights and other institutional matters affecting public health in a developing country
286
12 The TRIPS agreement and health innovation in Bangladesh
310
Index
325
Copyright

Other editions - View all

Common terms and phrases

About the author (2011)

Diego Sanchez-Ancochea is Lecturer in Economics at the Institute for the Study of the Americas at the University of London.
Kenneth C. Shadlen is Senior Lecturer at the Development Studies Institute (DESTIN) at the London School of Economics.

Bibliographic information